The substantial reduction in systemic inflammation, as indicated by high-sensitivity C-reactive protein (hs-CRP) levels, alongside improvements in overall metabolic health, such as weight loss and glycemic control, represents significant systemic alterations that may indirectly benefit the brain by mitigating chronic inflammatory stimuli and enhancing cerebrovascular health
Clinical vigilance is particularly important during the initial weeks of therapy and following dose increases
SGLT2 inhibitors are particularly effective in reducing the progression of diabetic nephropathy, whereas GLP-1 RAs are more beneficial for promoting weight loss and lowering the risk for major adverse cardiovascular events
CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions
"Compounding pharmacies are making their own versions of blockbuster weight loss drugs"
If your telehealth or local doctor prescribes the medication, you can have it sent to the local pharmacy of your choice